Co-Diagnostics
CODX
35 hedge funds and large institutions have $1.44M invested in Co-Diagnostics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 7 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
0.07% less ownership
Funds ownership: 0.58% → 0.51% (-0.07%)
8% less funds holding
Funds holding: 38 → 35 (-3)
20% less capital invested
Capital invested by funds: $1.81M → $1.44M (-$368K)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$39.3K |
| 2 |
JP Morgan Chase
New York
|
+$4.42K |
| 3 |
Renaissance Technologies
New York
|
+$3.34K |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$2.34K |
| 5 |
Citigroup
New York
|
+$1.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$84.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$59K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$27.5K |
| 4 |
BlackRock
New York
|
-$23.5K |
| 5 |
Squarepoint
New York
|
-$20.4K |
CODX Hedge Fund Activity: Q2 2025 in Review
35 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q2 2025, worth a combined $1.44M — down 20% from $1.81M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CODX and 4 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 9 added.
The largest buyer was Jane Street, adding an estimated $39.3K. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $84.5K sold.
- 35 institutional investors held Co-Diagnostics (CODX) as of Q2 2025, down from 38 in Q1 2025.
- Funds reported $1.44M of Co-Diagnostics stock for Q2 2025, down 20% quarter-over-quarter.
- 4 funds opened new Co-Diagnostics positions in Q2 2025 and 7 closed out, a net change of -3 holders.
- The largest Co-Diagnostics buyer in Q2 2025 was Jane Street, an estimated $39.3K added.
- The largest Co-Diagnostics seller in Q2 2025 was Bridgeway Capital Management, an estimated $84.5K sold.
Based on aggregated 13F filings for Q2 2025.